Food Irradiation·Food Science
KONG Hongming, YE Jiaxin, ZHAO Yating, ZHAO Nanxing, XIA Xudong, QI Xiangyang, CHEN Qiuping
To explore the mechanism of Eriobotrya japonica in the prevention and treatment of type 2 diabetes, Network pharmacology and molecular docking technology were used to explore the common target of loquat leaf and type 2 diabetes. In this study, TCMSP, Uniprot, Genecards, Venny, DAVID and other databases were used to map the interaction network and perform GO(Gene Ontology) and KEGG(Kyoto Encyclopedia of Genes and Genomes) enrichment analysis. The molecular docking was verified by autodock tools. 19 ingredients and 294 related targets were collected from TCMSP datebase, then 89 common targets of type 2 diabetes and loquat leaf active components were obtained in Venny 2.1.0, corresponding to 10 active substances such as EGCG, quercetin, kaempferol and β-sitosterol. Then the ‘active ingredient-disease target’ network map was constructed. The results indicated that the active components of loquat leaves regulated type 2 diabetes through regulating oxidative stress response, serine/threonine kinase activity, responding to lipopolysaccharide and epithelial cell proliferation, then regulating AGE-RAGE(Advanced glycation end products and the receptor for advanced glycation end products), HIF-1(Hypoxia inducible factor-1) and PI3K-Akt(Phosphatidylinositol 3 Kinase-protein kinase B) signaling pathways. The molecular docking results showed that the binding energy of the main active components on α-glucosidase was less than-9.0 kcal·mol-1, which had very strong binding activity. The semi-inhibitory concentrations of 7 active ingredient such as EGCG, quercetin and kaempferol on α-glucosidase were in the range of 1.11~80.04 μmol·L-1, as measured by in vitro enzyme activity assay. The inhibitory effects were better than those of acarbose, which can be used as efficient α-glucosidase inhibitor as the main active ingredient of loquat leaf in the prevention and treatment of type 2 diabetes. This study investigated the mechanism of active ingredients of loquat leaf on the prevention and treatment of type II diabetes, and provided research ideas for the follow-up development of hypoglycemic drugs from natural products.